Where is British American Tobacco going next in scaling New Categories for growth?
BAT's pivot matters: combustible volumes fell 8.1 percent in 2025, while New Categories revenue share rose in Q4 2025, signaling a make-or-break growth phase for non-combustible products.
Focus on accelerating consumer migration to vaping and heated tobacco; execution risk centers on regulation and manufacturing scale-up-see British American Tobacco SWOT Analysis.
Where Is British American Tobacco Trying to Go Next?
British American Tobacco is steering toward a Smokeless World, targeting 50 percent of Group revenue from smokeless products by 2035 and 50 million adult non-combustible users by 2030 (up from 34.1 million as of December 31, 2025). Key growth areas: vapour (Vuse), heated tobacco (glo), and modern oral (Velo), with heavy focus on the U.S., U.K., Germany, and Japan.
Core next growth opportunity: Scale non-combustible revenue
Expanding Vuse, glo, and Velo to convert combustible smokers and grow adult nicotine users is the primary commercial lever; smokeless revenue must rise from mid-2025 levels to hit the 50 percent by 2035 target, delivering margin and regulatory resilience.
Market expansion potential: Double down on the U.S. and select developed markets
The U.S. is the largest value pool where oral nicotine and vapour are accelerating; focused investment in U.S., U.K., Germany, and Japan can drive near-term volume and share gains while emerging markets offer long-term upside.
Product or service upside: Broaden modern oral and tech-enabled vapour
Scaling Velo (modern oral) and iterating Vuse hardware/software and glo consumables can lift average revenue per user and cross-sell across channels, especially given strong oral nicotine growth reported in 2025.
Most credible next move: Accelerate U.S. oral nicotine and vapour growth in 2025-2026
Given rebound in combustible performance and rapid oral nicotine expansion in the U.S. in 2025, the most realistic near-term win is scaling Velo and Vuse distribution and marketing in the U.S. and consolidating pricing and shelf placement.
Where British American Tobacco Is Trying to Go Next
BAT is shifting revenue mix toward non-combustibles, aiming for 50 million non-combustible adult consumers by 2030 and 50 percent smokeless revenue by 2035, prioritizing Vuse, glo, and Velo and concentrating investment in the U.S., U.K., Germany, and Japan.
- Primary growth opportunity: scale non-combustible portfolio (Vuse, glo, Velo) to hit smokeless revenue targets
- Expansion potential: deepen U.S. market penetration and strengthen positions in U.K., Germany, Japan
- Product upside: grow modern oral (Velo) and tech-enabled vapour (Vuse) to increase ARPU
- Most credible near-term driver: rapid U.S. oral nicotine and vapour expansion in 2025-2026
Who British American Tobacco Company Competes With
British American Tobacco SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Is British American Tobacco Building to Get There?
British American Tobacco is building a premium, non-combustible portfolio and a leaner cost base to turn category growth into cash flow; it focuses on next – generation products, nicotine pouches, and a Fit to Win cost program to fund expansion and protect margins.
Expansion into Premium Next – Gen and New Geographies
BAT is prioritising scale in the U.S., Japan and selected emerging markets through Vuse, glo and Velo rollouts and wider retail distribution to capture premiumisation and higher-margin consumption.
Product and Service Innovation: Premiumisation and Category Stretch
Launches like Vuse Ultra, glo Hilo, Velo Shift and the U.S. Velo Plus expansion drive premium pricing, intake of nicotine pouch users and faster category share gains; Velo Plus posted triple – digit revenue growth and reached number two in U.S. volume and value within its first year.
Technology, Data and Automation to Improve Unit Economics
BAT is deploying digital marketing, CRM analytics and factory automation to shorten product cycles, increase conversion for vaping and pouch customers, and reduce production cost per unit.
Partnerships and M&A to Accelerate New Categories
Strategic alliances, targeted M&A and licensing deals expand pouch and heated tobacco footprints and speed shelf entry vs organic only approaches.
Investment, Fit to Win and Execution Discipline
BAT targets £600 million of annualised savings by 2028 under Fit to Win while guiding to a net debt / adjusted EBITDA ratio of 2.0-2.5x by end – 2026 to fund New Category capex and marketing.
Most Important Strategic Build: Scale in Nicotine Pouches (U.S.)
The rapid U.S. Velo Plus rollout-achieving triple – digit revenue growth and top – two share-matters most in 2025/2026 because pouches are higher – margin, faster to scale and less exposed to combustible regulation.
Execution Roadmap: What It Is Building to Get There
BAT is converting product innovation into share and cash by combining premium next – generation products with cost savings and balance – sheet discipline to fund rapid New Category expansion.
- Scale premium next – gen products (Vuse Ultra, glo Hilo, Velo Shift, Velo Plus)
- Drive premiumisation and retention via product upgrades and pricing
- Use partnerships, selective M&A and digital marketing to speed market entry
- Prioritise Fit to Win savings (£600 million by 2028) and a net debt / EBITDA target of 2.0-2.5x by end – 2026
Read more context on operational approach and culture in this company overview How British American Tobacco Company Runs
British American Tobacco PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What Could Slow British American Tobacco Down?
Regulatory shocks, illicit competition, and intense rival rivalry could materially slow British American Tobacco's growth toward 2035; legal payouts and cash drains further constrain free cash flow and strategic flexibility.
Weakening Demand and Market Saturation
Softening consumer uptake for vapour and nicotine alternatives in core markets would limit sales growth; shifting buying behaviour toward illicit or cheaper substitutes depresses volumes and pricing power.
Competition and Pricing Pressure
glo faces stiff competition from Philip Morris's IQOS and independent vape brands, forcing promotional activity and margin erosion as BAT defends share in heated tobacco and next generation products.
Execution and Investment Risk
Large capex and M&A bets to scale BAT diversification strategy may underdeliver; integration frictions or slower rollouts of reduced-risk products (RRP) can push breakeven timelines and lower returns.
Regulation, Technology, and External Disruption
Fast-moving regulation-eg France's 2025 ban that forced Velo nicotine pouches off shelves-plus illicit vapour proliferation in the U.S. and supply shocks could abruptly limit market access and revenue.
Key Headwinds That Could Slow British American Tobacco
Regulatory volatility, illicit-market leakage, and competitive displacement are the clearest constraints on British American Tobacco future; combined with material cash outflows like the £2.6 billion 2025 Canadian litigation payment, these risks compress free cash flow and strategic optionality.
- Demand and pricing pressure from cheaper illicit vapour and shifting consumer preferences
- Execution risk from scaling BAT next generation products and integrating diversification moves
- Regulatory shocks and market bans that restrict nicotine pouch and vape distribution
- The single biggest risk: sustained regulatory and illicit-market disruption that undermines revenue for BAT strategic direction
For context on customer cohorts and market positioning see Who British American Tobacco Company Serves
British American Tobacco SOAR Analysis
- Complete SOAR Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
How Strong Does British American Tobacco's Growth Story Look?
British American Tobacco's growth story looks mixed but credible: resilient combustible cash flows fund a clear push into modern oral and other next-generation products, positioning for moderate expansion rather than rapid acceleration.
Growth Direction: Measured Pivot, Not a Leap
The British American Tobacco future is a deliberate pivot from combustibles to next-generation products; overall outlook is mixed because legacy combustibles still drive cash while New Categories scale. Expect moderate expansion as BAT strategic direction balances defense of margins with targeted growth bets.
Near-Term Growth Signals: Solid 2025, Conservative 2026 Guide
2025 showed U.S. combustibles delivering strong revenue and profit growth and New Categories growing 7.0 percent for the year; 2026 guidance is conservative at revenue growth of 3-5 percent and adjusted diluted EPS growth toward the lower end of 5-8 percent, signalling cautious management assumptions.
Strategic Support for Growth: Reinvesting Combustible Cash
BAT diversification strategy uses combustible cash to fund scale-up in modern oral (nicotine pouches), heated tobacco, and vapes, plus selective M&A and marketing to accelerate penetration in key markets like the U.S. and Brazil.
Upside Potential: Modern Oral Momentum
Modern oral (nicotine pouches) momentum is the most credible upside; if adoption and pricing trends in 2025 continue, BAT could materially lift margins and revenue mix, supporting faster BAT next generation products scale.
Downside Risk to the Outlook: Regulation
Regulatory action-taxes, flavor bans, or tighter rules on nicotine alternatives-remains the biggest single risk that could derail the British American Tobacco outlook despite competent execution.
Overall Growth Judgment: Convincing but Conditional
The growth story is convincing at the category level-combustibles funding New Categories scaling-but fragile at the company level because outcomes hinge on external regulation and market adoption rates.
How Strong the Growth Story Looks
British American Tobacco appears set for moderate expansion: stable combustible cash flows plus credible traction in modern oral and heated products create a realistic, if not aggressive, growth path through 2026.
- Positioning: geared for moderate expansion, not rapid growth
- Most supportive near-term signal: U.S. combustibles strength and 7.0 percent New Categories growth in 2025
- Biggest upside: accelerated adoption of nicotine pouches and successful pricing in modern oral
- Main downside risk: adverse regulatory changes across core and next-generation products
For context on heritage and strategic evolution, see History of British American Tobacco Company Explained
British American Tobacco VRIO Analysis
- Covers VRIO Analysis in Details
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What Does British American Tobacco Company Stand For?
- How Did British American Tobacco Company Become What It Is Today?
- Who Owns British American Tobacco Company and Why Does It Matter?
- How Does British American Tobacco Company Actually Work?
- How Does British American Tobacco Company Sell Its Products and Services?
- Who Does British American Tobacco Company Serve?
- Who Does British American Tobacco Company Compete With?
Frequently Asked Questions
British American Tobacco is shifting toward a Smokeless World. Its goal is 50 percent of Group revenue from smokeless products by 2035 and 50 million adult non-combustible users by 2030, with Vuse, glo, and Velo leading the push in the U.S., U.K., Germany, and Japan.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.